NewGenIVF FY2025 Results: Net Profit Hits $9.9M, K25.ai Stake Surges
NewGenIVF Group Limited delivered a net profit of US$9.9 million for FY2025, with net assets at US$25.98 million. The company’s 13% stake in K25.ai is now valued at ~US$26 million, driven by a US$200 million implied valuation for the AI firm. This creates an expected unrealized gain of ~US$8.5 million. Additionally, NewGen expects its outstanding Class A shares to reach ~5.9 million following a planned issuance of 2.5 million shares.

*this image is generated using AI for illustrative purposes only.
NewGenIVF Group Limited (NASDAQ: NIVF) reported a net profit attributable to shareholders of US$9.9 million for the fiscal year ended December 31, 2025, while its strategic investment in K25.ai has appreciated to a value of approximately US$26 million. The company’s net assets stood at approximately US$25.98 million as of year-end, but the financial position has been further strengthened in 2026 by the valuation uplift in its AI-focused subsidiary stake. This unrealized gain of approximately US$8.5 million represents a material enhancement to the balance sheet, reflecting the growth trajectory of K25.ai since the initial investment.
The valuation update is based on a current implied valuation of US$200 million for K25.ai. NewGen holds an agreed 13% stake in the entity, which remains subject to the completion of acquisitions in accordance with applicable share purchase agreements. Management indicated that this appreciation underscores the continued progress of K25.ai and contributes positively to NewGen’s overall capitalization structure.
Investment Valuation Details
The following table outlines the key metrics regarding NewGen’s investment in K25.ai as disclosed in the update:
| Metric | Value |
|---|---|
| Implied Valuation of K25.ai | US$200 million |
| NewGen’s Stake Percentage | 13% |
| Current Value of Stake | ~US$26 million |
| Expected Unrealized Gain | ~US$8.5 million |
The stake remains contingent upon the finalization of specific acquisition transactions as defined in the share purchase agreements. Until these conditions are met, the value is classified as an expected unrealized gain rather than realized income.
Capitalization and Share Structure
In addition to the investment update, NewGen provided details on its equity structure. Upon the completion of the issuance of 2,500,000 Class A ordinary shares, as previously announced on July 27, 2026, the company’s total outstanding Class A ordinary share count is expected to reach approximately 5,900,000. This issuance is part of the broader capitalization strategy tied to the K25.ai investment framework.
What the Numbers Show
The most significant aspect of this update is the disproportionate impact of the unrealized gain relative to the company’s reported net assets. With net assets at approximately US$25.98 million for FY2025, the potential US$8.5 million unrealized gain from the K25.ai stake represents a substantial percentage increase in total equity value if realized. This highlights NewGen’s strategic pivot towards high-growth technology assets, where balance sheet strength is increasingly driven by valuation multiples of its portfolio companies rather than solely by operational cash flows. The pending nature of the acquisition completions introduces execution risk, but the implied valuation signals strong market confidence in K25.ai’s underlying technology and growth prospects.
What specific milestones or regulatory approvals must K25.ai achieve to finalize the pending acquisitions and convert the unrealized gain into realized income?
How might the issuance of 2.5 million new Class A shares impact existing shareholder dilution and earnings per share in the near term?
Given the heavy reliance on K25.ai's valuation for balance sheet strength, what are the risks if the AI sector experiences a broader market correction?



























